References
- Nakagawa T, Ito J. Drug delivery systems for the treatment of sensorineural hearing loss. Acta Otolaryngol Suppl 2007; 557: 30–5
- Young S, Wong M, Tabata Y, Mikos A. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release 2005; 109: 256–74
- Endo T, Nakagawa T, Kita T, Iguchi F, Kim T, Tamura T, et al. Novel strategy for treatment of inner ears using a biodegradable gel. Laryngoscope 2005; 115: 2016–20
- Iwai K, Nakagawa T, Endo T, Matsuoka Y, Kita T, Kim T, et al. Cochlear protection by local insulin-like growth factor-1 application using biodegradable hydrogel. Laryngoscope 2006; 116: 529–33
- Lee K, Nakagawa T, Okano T, Hori R, Ono K, Tabata Y, et al. Novel therapy for hearing loss: delivery of insulin-like growth factor 1 to the cochlea using gelatin hydrogel. Otol Neurotol 2007; 28: 976–81
- Gohda E, Tsubouchi H, Nakayama H, Hirono S, Sakiyama O, Takahashi K, et al. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 1988; 81: 414–19
- Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989; 342: 440–3
- Funakoshi H, Nakamura T. Hepatocyte growth factor: from diagnosis to clinical applications. Clin Chim Acta 2003; 327: 1–23
- Oshima K, Shimamura M, Mizuno S, Tamai K, Doi K, Morishita R, et al. Intrathecal injection of HVJ-E containing HGF gene to cerebrospinal fluid can prevent and ameliorate hearing impairment in rats. FASEB J 2004; 18: 212–14
- Ozeki M, Ishii T, Hirano Y, Tabata Y. Controlled release of hepatocyte growth factor from gelatin hydrogels based on hydrogel degradation. J Drug Target 2001; 9: 461–71
- Viberg A, Canlon B. The guide to plotting a cochleogram. Hear Res 2004; 197: 1–10
- Wang J, Ruel J, Ladrech S, Bonny C, van de Water TR, Puel JL. Inhibition of the c-Jun N-terminal kinase-mediated mitochondrial cell death pathway restores auditory function in sound-exposed animals. Mol Pharmacol 2007; 71: 654–66
- Tanaka K, Takemoto T, Sugahara K, Okuda T, Mikuriya T, Takeno K, et al. Post-exposure administration of edaravone attenuates noise-induced hearing loss. Eur J Pharmacol 2005; 522: 116–21
- Hu B, Guo W, Wang P, Henderson D, Jiang S. Intense noise-induced apoptosis in hair cells of guinea pig cochleae. Acta Otolaryngol 2000; 120: 19–24
- Ohlemiller K, Wright J, Dugan L. Early elevation of cochlear reactive oxygen species following noise exposure. Audiol Neurootol 1999; 4: 229–36
- Yamashita D, Minami S, Kanzaki S, Ogawa K, Miller J. Bcl-2 genes regulate noise-induced hearing loss. J Neurosci Res 2008; 86: 920–8
- Nakagami H, Morishita R, Yamamoto K, Taniyama Y, Aoki M, Matsumoto K, et al. Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells. Hypertension 2001; 37(2 Part 2)581–6
- Kitamura K, Iwanami A, Nakamura M, Yamane J, Watanabe K, Suzuki Y, et al. Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injury. J Neurosci Res 2007; 85: 2332–42
- Ruel J, Wang J, Rebillard G, Eybalin M, Lloyd R, Pujol R, et al. Physiology, pharmacology and plasticity at the inner hair cell synaptic complex. Hear Res 2007; 227: 19–27